Fang is a principal based in Versant’s Basel, Switzerland, office. He brings relevant skills and experience sourcing new opportunities and leading transactions across the fields of oncology, immunology, infectious and rare diseases.
Fang previously worked within Roche’s business development organizations in the U.S. and Europe. In his most recent role as Director, Global Oncology and Immuno-Oncology Business Development & Licensing, he was intimately involved in constructing an innovation strategy for cancer immunology and the molecular targeted therapy landscapes.
Fang earned a Doctor of Pharmacy degree from Purdue University, and then completed a post-doctoral fellowship at Rutgers University.